Skip to main content
SpringerLink
Log in

Variable Response to a Candidate Cancer Vaccine Antigen: MHC Control of the Antibody Response in the Rat to Avian Erythroblastosis Virus (AEV)-Encoded Epithelial Growth Factor Receptor but Not AEV-Encoded Thyroid Hormones Receptor

  • Original Articles
  • Published:
Molecular Medicine Aims and scope Submit manuscript

Abstract

Background

A problem likely to be encountered in any cancer immunotherapy based on vaccination with a single protein or peptide is variation in the host response. A particularly informative example is provided by the two oncogenic proteins, one intracellular and the other extracellular, encoded by the avian erythroblastosis virus (AEV), homologs of the thyroid hormones receptor (THsR) and the epithelial growth factor receptor (EGFR), respectively.

Materials and Methods

Antibodies to these two proteins were assayed by radioimmune precipitation (RIP) in sera from MHC-congenic rats immunized by virally induced tumors.

Results

Among the four haplotypes tested, RT11 rats exhibited a significantly lower response to the EGFR homolog than the high responders RT1c and RT1u, while RT1a rat strains had an intermediate response. Analysis of the recombinant haplotype RT1ac indicated that the response is controlled, as expected, by the class II locus of the MHC. In contrast, these rat strains responded uniformly to the intracellular THsR homolog.

Conclusions

These results support the hypothesis that MHC restriction of the response to self-related proteins reflects mainly a tolerance mechanism. They sound a note of warning for cancer vaccine development, and also one of positive advice. The likelihood of MHC restriction suggests that a widely applicable polyvalent vaccine should be the final aim in cancer immunotherapy. Yet, paradoxically, evidence of MHC restriction can help establish that a candidate vaccine is likely to prove effective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Urban JL, Schreiber H. (1992) Tumor antigens. Annu. Rev. Immunol 10: 617–644.

    Article  CAS  PubMed  Google Scholar 

  2. Mitchison NA. (1994) The immunogenicity of tumors. In: Forni G (ed). Cytokine-Induced Tumor Immunogenicity. Academic Press, New York, pp. 3–11.

    Google Scholar 

  3. Disis ML, Smith JW, Murphy AE, Chen W, Cheever MA. (1994) In vitro generation of human cytolytic T-cells specific for peptides derived from the HUER-2/neu protooncogene protein. Cancer Res. 54: 1071–1076.

    PubMed  CAS  Google Scholar 

  4. Ishida T, Tsujisaki M, Hanzawa Y, et al. (1994) Significance of erbB-2 gene product as a target for cancer therapy. Scand. J. Immunol. 39: 459–466.

    Article  CAS  PubMed  Google Scholar 

  5. Natali PG, Nicotra MR, Digiesi G, et al. (1994) Expression of gp185HER-2 in human cutaneous melanoma: Implications for experimental immunotherapeutics. Int. J. Cancer 56: 341–346.

    Article  CAS  PubMed  Google Scholar 

  6. Libermann TA, Nusbaum HR, Razon N, et al. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313: 144–147.

    Article  CAS  PubMed  Google Scholar 

  7. Watanabe H, Okumura M, Hirayama K, Sasazuki T. (1990) HLA-Bw54-DR4-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis-B surface antigen via CD8-positive suppressor T cells. Tissue Antigens 36: 69–74.

    Article  CAS  PubMed  Google Scholar 

  8. Talwar GP, Sigh O, Pal R, et al. (1994) A vaccine that prevents pregnancy in women. Proc. Natl. Acad. Sci. U.S.A. 91: 8532–8536.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Hayman MJ, Ramsay GM, Savin K, Kitchener G. (1983) Identification and characterization of the avian erythrobalstosis virus gene product as a membrane glycoprotein. Cell 32: 579–588.

    Article  CAS  PubMed  Google Scholar 

  10. Damm K, Beug H, Graf T, Vennstrom B. (1987) A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenes. E.M.B.O. J. 6: 375–382.

    CAS  Google Scholar 

  11. Cortese Hassett AL, Misra DN, Kunz HW, Gill III TJ. (1991) The major histocompatibility complex of the rat. In: Srivastava R, Ram BP, Tyle P (eds). Immunogenetics of the Major Histocompatibility Complex. VCH publishers, New York, pp. 309–347.

    Google Scholar 

  12. Sette A, Sidney J, Gaeta FC, et al. (1993) MHC class II molecules bind indiscriminately self and non-self peptide homologs: Effect on the immunogenicity of non-self peptides. Int. Immunol 5: 631–638.

    Article  CAS  PubMed  Google Scholar 

  13. Salvat S, Auger I, Rochelle L, et al. (1994) Tolerance of a self-peptide from the third hypervariable region of HLA DRB1 * 0401 in rheumatoid arthritis patients and normal subjects. J. Immunol 153: 5321–5329.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Drs. G. W. Butcher and M. J. Hayman for guidance in this work.

Author information

Author notes

  1. Nicholas A. Mitchison

    Present address: Deutsches Rheuma-Forschungszentrum, Nordufer 20, 13353, Berlin, Germany

  2. Nance Nardi

    Present address: Laboratorio de Imunogenetica, Universidade Federal del Rio Grande do Sul, Avenida Bento Goncalves, 9500, Porto Alegre, Rio Grande do Sul, CEP90.000, Brazil

Authors and Affiliations

  1. Imperial Cancer Research Fund Tumor Immunology Unit, University College London, London, UK

    Nance Nardi & Nicholas A. Mitchison

Authors
  1. Nance Nardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicholas A. Mitchison
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nardi, N., Mitchison, N.A. Variable Response to a Candidate Cancer Vaccine Antigen: MHC Control of the Antibody Response in the Rat to Avian Erythroblastosis Virus (AEV)-Encoded Epithelial Growth Factor Receptor but Not AEV-Encoded Thyroid Hormones Receptor. Mol Med 1, 563–567 (1995). https://doi.org/10.1007/BF03401593

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401593

Search

Navigation